Lyell Immunopharma, Inc. ($LYEL)
Filing Information
| Accession Number | 0001866154-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
69,109
Total Value
$2,520.08
P&L
+inf% (+$1,319,280.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Feb 9, 2026 | Grant/Award | 4,000 | $0.00 | $0.00 | 19,140 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 10, 2026 | Sale | 109 | $23.12 | $2,520.08 | 19,031 | Direct | โ | View Details | |
Chief Operating Officer | Option (right to buy) | Derivative | Feb 10, 2026 | Grant/Award | 65,000 | $0.00 | $0.00 | 65,000 | Direct | โ | View Details |